ATE486609T1 - Furin-hemmer zur behandlung von fibrose und narbenbildung - Google Patents
Furin-hemmer zur behandlung von fibrose und narbenbildungInfo
- Publication number
- ATE486609T1 ATE486609T1 AT03765179T AT03765179T ATE486609T1 AT E486609 T1 ATE486609 T1 AT E486609T1 AT 03765179 T AT03765179 T AT 03765179T AT 03765179 T AT03765179 T AT 03765179T AT E486609 T1 ATE486609 T1 AT E486609T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- fibrosis
- scar formation
- furin inhibitors
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0217136.1A GB0217136D0 (en) | 2002-07-24 | 2002-07-24 | Wound healing & treatment of fibrosis |
PCT/GB2003/003159 WO2004009113A1 (en) | 2002-07-24 | 2003-07-23 | Use of convertase inhibitors in the treatment of fibrosis and scarring |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE486609T1 true ATE486609T1 (de) | 2010-11-15 |
Family
ID=9941004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03765179T ATE486609T1 (de) | 2002-07-24 | 2003-07-23 | Furin-hemmer zur behandlung von fibrose und narbenbildung |
Country Status (12)
Country | Link |
---|---|
US (2) | US7700562B2 (de) |
EP (1) | EP1556080B1 (de) |
JP (1) | JP4630661B2 (de) |
AT (1) | ATE486609T1 (de) |
AU (1) | AU2003254473B2 (de) |
CA (1) | CA2492331A1 (de) |
DE (1) | DE60334830D1 (de) |
DK (1) | DK1556080T3 (de) |
ES (1) | ES2355094T3 (de) |
GB (1) | GB0217136D0 (de) |
HK (1) | HK1073438A1 (de) |
WO (1) | WO2004009113A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007505887A (ja) * | 2003-09-16 | 2007-03-15 | ファルマシア・コーポレーション | 関節炎治療のためのpace4阻害剤 |
WO2005037150A1 (en) * | 2003-10-16 | 2005-04-28 | Osteotech, Inc. | System and method for flexible correction of bony motion segment |
WO2008066707A2 (en) * | 2006-11-29 | 2008-06-05 | Dana-Farber Cancer Institute | Targeting prohormone convertase enzymes to suppress pomc-msh processing to induce skin lightening |
GB0724231D0 (en) * | 2007-12-12 | 2008-01-30 | Renono Ltd | Methods for inhibiting scarring |
CA2727574C (en) | 2008-07-11 | 2018-02-20 | Socpra-Sciences Et Genie S.E.C. | Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents |
AU2011340200B2 (en) * | 2010-12-06 | 2017-04-06 | The University Of British Columbia | Granzyme B inhibitor compositions, methods and uses for promoting wound healing |
JP6472608B2 (ja) | 2014-05-21 | 2019-02-20 | ソマール株式会社 | N−アセチルグルコサミン糖鎖基含有化合物、薬剤輸送用キャリアー化合物、製剤、及び、薬剤輸送システム |
WO2017141032A1 (en) * | 2016-02-15 | 2017-08-24 | Oxford University Innovation Limited | Treatment of fibrotic disorders |
FR3110345B1 (fr) | 2020-05-21 | 2024-03-29 | Agence Francaise Pour Le Dev D’Al Ula | Hydrolysat de protéines du tourteau des graines de Moringa peregrina pour son application en tant que médicament, son procédé d’obtention et compositions pharmaceutiques, dermatologiques et cosmétiques. |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0356595A1 (de) | 1988-09-01 | 1990-03-07 | Merrell Dow Pharmaceuticals Inc. | Peptidase-Hemmer |
ZA897515B (en) | 1988-10-07 | 1990-06-27 | Merrell Dow Pharma | Novel peptidase inhibitors |
US5874479A (en) * | 1991-03-01 | 1999-02-23 | Warner-Lambert Company | Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same |
GB9106678D0 (en) | 1991-03-28 | 1991-05-15 | Ferguson Mark W J | Wound healing |
GB9205800D0 (en) | 1992-03-17 | 1992-04-29 | British Tech Group | Treatment of fibrotic disorders |
US5439824A (en) * | 1993-05-06 | 1995-08-08 | The United States Of America | Increased expression of α-1-antitrypsin in expression vectors through the inclusion of intron II |
GB9314350D0 (en) | 1993-07-12 | 1993-08-25 | Zeneca Ltd | Armide derivatives |
DE69535976D1 (de) | 1994-03-29 | 2009-08-13 | Renovo Ltd | Heilung von Wunden oder fibrotischen Krankheiten unter Verwendung von wenigstens einem Agens gegen einen Wachstumsfaktor |
GB2324960A (en) | 1997-05-09 | 1998-11-11 | Univ Manchester | Delivery of naked DNA for wound healing |
EP2130532A1 (de) * | 1999-01-05 | 2009-12-09 | University of Utah Research Foundation | Verfahren zur Behandlung von mit der Akkumulation von überschüssiger extrazellulärer Matrix assoziierten Zuständen |
US6262020B1 (en) * | 2000-02-15 | 2001-07-17 | Alphamed Pharmaceuticals Corp. | Topical wound therapeutic compositions |
CA2312109A1 (en) * | 2000-06-23 | 2001-12-23 | Universite De Sherbrooke | Use of furin and furin-like protease inhibitors in the treatment of inflammatory or matrix remodelling diseases |
US6509318B1 (en) * | 2000-09-29 | 2003-01-21 | The Regents Of The University Of California | TGF-B inhibitors and methods |
US7033991B2 (en) * | 2001-07-16 | 2006-04-25 | Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College | Inhibiting furin with polybasic peptides |
-
2002
- 2002-07-24 GB GBGB0217136.1A patent/GB0217136D0/en not_active Ceased
-
2003
- 2003-07-23 AU AU2003254473A patent/AU2003254473B2/en not_active Ceased
- 2003-07-23 US US10/522,222 patent/US7700562B2/en not_active Expired - Fee Related
- 2003-07-23 WO PCT/GB2003/003159 patent/WO2004009113A1/en active Application Filing
- 2003-07-23 AT AT03765179T patent/ATE486609T1/de not_active IP Right Cessation
- 2003-07-23 JP JP2004522337A patent/JP4630661B2/ja not_active Expired - Fee Related
- 2003-07-23 CA CA002492331A patent/CA2492331A1/en not_active Abandoned
- 2003-07-23 DK DK03765179.1T patent/DK1556080T3/da active
- 2003-07-23 DE DE60334830T patent/DE60334830D1/de not_active Expired - Lifetime
- 2003-07-23 EP EP03765179A patent/EP1556080B1/de not_active Expired - Lifetime
- 2003-07-23 ES ES03765179T patent/ES2355094T3/es not_active Expired - Lifetime
-
2005
- 2005-07-29 HK HK05106520.1A patent/HK1073438A1/xx unknown
-
2009
- 2009-11-23 US US12/624,248 patent/US20110059896A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004009113A1 (en) | 2004-01-29 |
EP1556080A1 (de) | 2005-07-27 |
US7700562B2 (en) | 2010-04-20 |
EP1556080B1 (de) | 2010-11-03 |
US20110059896A1 (en) | 2011-03-10 |
ES2355094T3 (es) | 2011-03-22 |
AU2003254473B2 (en) | 2008-05-01 |
AU2003254473A1 (en) | 2004-02-09 |
HK1073438A1 (en) | 2005-10-07 |
CA2492331A1 (en) | 2004-01-29 |
JP4630661B2 (ja) | 2011-02-09 |
DK1556080T3 (da) | 2011-01-31 |
US20060052309A1 (en) | 2006-03-09 |
JP2005535674A (ja) | 2005-11-24 |
GB0217136D0 (en) | 2002-09-04 |
DE60334830D1 (de) | 2010-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1073438A1 (en) | Furin inhibitors for use in the treatment of fibrosis and scarring | |
ATE489957T1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
ATE376835T1 (de) | Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis | |
MXPA04001033A (es) | Compuesto de sanado para heridas y anti-cancer. | |
EP2059205A4 (de) | Verfahren zur herstellung eines festen verbands zur behandlung von verletztem gewebe | |
ATE512163T1 (de) | Verabreichung von mitteln zur behandlung von entzündungen | |
ATE414556T1 (de) | Verwendung von il-18-inhibitoren zur behandlung und/oder prävention von peripheren gefässkrankheiten | |
ATE452642T1 (de) | Verwendung von cox-2 inhibitoren zur behandlung von affectiven störungen | |
SE0200667D0 (sv) | Novel use of cytokine inhibitors | |
DE60231050D1 (de) | Verwendung von Totarol zur Behandlung von Pruritus | |
ATE404202T1 (de) | Die verwendung von potenten, selektiven und nontoxischen c-kithemmern zur behandlung von interstitieller blasenentzündung | |
ATE390928T1 (de) | Zusammensetzungen zur behandlung von hauterkrankungen | |
ATE256461T1 (de) | Benutzung von comt-inhibitoren als analgetika | |
DE60044584D1 (de) | Protease from lucilia sericata und deren verwendung zur wundheilung | |
ATE454155T1 (de) | Verwendung von drospirenon zur behandlung von hypertension | |
DE69920015D1 (de) | Verfahren zur induktion der herstellung von wachstumsfaktoren | |
ATE338566T1 (de) | Aldosteronantagonist und cyclooxygenase-2 hemmer- kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten | |
MXPA04011018A (es) | Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias. | |
WO2007075853A3 (en) | Protease compositions for the treatment of damaged tissue | |
ATE270895T1 (de) | Topische verwendung von ätherischen ölen zur behandlung von wundheilungsstörungen | |
MXPA04007007A (es) | Uso de inhibidores del intercambiador cloruro/bicarbonato dependiente del sodio para el tratamiento de enfermedades tromboticas e inflamatorias. | |
ATE302023T1 (de) | Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen | |
DE60326348D1 (de) | Makrozyclen zur behandlung von krebserkrankungen | |
ATE390144T1 (de) | Behandlung von fibrosen | |
ATE526954T1 (de) | Atomoxetin zur behandlung von allergischer rhinitis und asthma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |